Lymphocyte Activation Gene 3 Single-Nucleotide Polymorphisms in Bone Marrow Failure Diseases
Open Access
- 27 February 2022
- journal article
- research article
- Published by Wiley in Analytical Cellular Pathology
- Vol. 2022, 1-6
Abstract
Introduction. Lymphocyte activation gene 3 (LAG3) is an inhibitory checkpoint protein expressed on activated T effector, T regulatory, and natural killer cells. The main function of LAG3 is the regulation of immune homeostasis. Several studies have suggested its role in malignant and autoimmune diseases. The objective of this study was to explore the association between LAG3 single-nucleotide polymorphisms (SNPs) and bone marrow failure diseases. Methods. Sixty-two patients newly diagnosed with bone marrow failure diseases in the Hematology Department of Tianjin Medical University General Hospital between January 2019 and December 2020 and 16 healthy controls were enrolled in this study. SNPs in LAG3 were investigated by performing Sanger sequencing, and the association of the detected SNPs with bone marrow failure diseases was analyzed. Results. Eleven SNPs were identified. Among them, the frequency of LAG3 rs1941928301 (C>T) was statistically different among the groups ( ). It was higher in the myelodysplastic syndrome (MDS) group than that in the severe aplastic anemia (SAA) group ( ) and that in the healthy control group ( ). Conclusions. LAG3 rs1941928301 (C>T) might be associated with a higher risk of MDS. The detected LAG3 SNPs have no apparent effect on susceptibility to SAA and immune-related pancytopenia (IRP).Keywords
Funding Information
- Scientific Research Project of Tianjin Educational Committee (2020KJ149, RC20007, ZYYFY2019029, 18ZXDBSY00140, 81970116, 81870101, 81770118)
- Science and Technology Project of Tianjin Municipal Health Commission (2020KJ149, RC20007, ZYYFY2019029, 18ZXDBSY00140, 81970116, 81870101, 81770118)
- Zhao Yi-Cheng Medical Science Foundation (2020KJ149, RC20007, ZYYFY2019029, 18ZXDBSY00140, 81970116, 81870101, 81770118)
- Natural Science Foundation of Tianjin Municipality (2020KJ149, RC20007, ZYYFY2019029, 18ZXDBSY00140, 81970116, 81870101, 81770118)
- National Natural Science Foundation of China (2020KJ149, RC20007, ZYYFY2019029, 18ZXDBSY00140, 81970116, 81870101, 81770118)
This publication has 24 references indexed in Scilit:
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemiaBlood, 2016
- Lymphocyte Activation Gene 3 (LAG-3) Modulates the Ability of CD4 T-cells to Be Suppressed In VivoPLOS ONE, 2014
- Lymphocyte Activation Gene-3 (LAG-3) Negatively Regulates Environmentally-Induced AutoimmunityPLOS ONE, 2014
- Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune EscapeCancer Research, 2012
- Cutting Edge: Accelerated Autoimmune Diabetes in the Absence of LAG-3The Journal of Immunology, 2011
- Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemiaBlood, 2011
- LAG-3 in Cancer Immunotherapy2010
- Common single nucleotide polymorphisms in immunoregulatory genes and multiple myeloma risk among women in ConnecticutAmerican Journal of Hematology, 2010
- Guidelines for the diagnosis and management of aplastic anaemiaBritish Journal of Haematology, 2009
- The negative regulatory function of the lymphocyte‐activation gene‐3 co‐receptor (CD223) on human T cellsImmunology, 2005